Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Prevention, Treatment, and Pulmonary Rehabilitation of Post-Tuberculosis Lung Disease Via Approaches That Reveal Mechanisms and Identify Diagnostic, Progression, and Treatment-Response Markers

NCT07731009 is registered in ClinicalTrials.gov with Jose Antonio Dominguez Benitez as lead sponsor.

NCT NCT07731009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Prevention, Treatment, and Pulmonary Rehabilitation of Post-Tuberculosis Lung Disease Via Approaches That Reveal Mechanisms and Identify Diagnostic, Progression, and Treatment-Response Markers
Lead sponsor
Jose Antonio Dominguez Benitez
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2031
Enrollment
760 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post tuberculosis